Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of Biodynamic Imaging for Predicting Effect of Gemcitabine and Nab-paclitaxel on Metastatic Adenocarcinoma of the Pancreas

NCT02205788 is registered in ClinicalTrials.gov with Patrick Joseph Loehrer Sr. as lead sponsor.

NCT NCT02205788
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02205788 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of Biodynamic Imaging for Predicting Effect of Gemcitabine and Nab-paclitaxel on Metastatic Adenocarcinoma of the Pancreas
Lead sponsor
Patrick Joseph Loehrer Sr.
Phase
Observational
Overall status
Withdrawn
Start date
July 31, 2014
Completion date
September 14, 2016
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic pancreatic cancer